Prime Therapeutics appoints Ellyn Hosch as chief information officer

     Prime Therapeutics appoints Ellyn Hosch as chief information officer

PR Newswire

ST. PAUL, Minn., April 3, 2013

ST. PAUL, Minn., April 3, 2013 /PRNewswire/ -- Prime Therapeutics (Prime), a
leading pharmacy benefit manager (PBM), announced today that it has promoted
Ellyn Hosch to chief information officer (CIO).

"Ellyn's industry experience, combined with her knowledge of Prime and clear
vision for our future, will support the company's significant growth," said
Eric Elliott, president and CEO at Prime Therapeutics.

Hosch joined Prime in 2008 as vice president of application development and
support. In that role, she led insourcing of Prime's claims processing system,
RxCLAIM, which was successfully completed in 2011. She has also been
instrumental in shaping and implementing the strategy for improving internal
IT development and support processes to ensure application stability and
availability. Over the last five years, Ellyn has progressively increased her
scope of responsibility and contribution to Prime.

Prior to joining Prime, Hosch held leadership roles at Diversified
Pharmaceutical Services, HealthPartners and UnitedHealth Group.

She has a Masters of Business Administration from the University of St. Thomas
and an undergraduate degree from the University of Minnesota.

About Prime Therapeutics
Prime Therapeutics (Prime) helps people get the medicine they need to feel
better and live well. Prime offers coverage for medications to health
insurers, employers, seniors on Medicare and individuals. The company
processes claims and delivers medicine to members, offering clinical services
for people with complex medical conditions. Headquartered in St. Paul, Minn.,
Prime serves nearly 20 million people. It is owned by 13 Blue Cross and Blue
Shield Plans, subsidiaries or affiliates of those plans. Prime has been
recognized as one of the fastest-growing private companies in the nation.

For more information, visit or follow @Prime_PBM on

SOURCE Prime Therapeutics

Contact: Sheila Thelemann, Prime Therapeutics, Director, Corporate
Communication, 612.777.5508,
Press spacebar to pause and continue. Press esc to stop.